Research

When possible, we use a scientific approach and take pride in developing new knowledge to share with others. Our research team is broad, varied, and enthusiastic.

In health care research, U.S.-based faculty leadership comes from Dartmouth’s Geisel School of Medicine and Dartmouth Cancer Center. In Honduras, “UNICAH,” which is the Universidad Catolica de Honduras is the base. Coordinating throughout Latin America and the Caribbean, the organization Latin-American and Caribbean Society of Medical Oncology (SLACOM) in Buenos Aires has been essential. Key personnel are from those organizations and study coordinators are recruited from UNICAH’s Student Research Association and their PESCA program designed to prevent cancer.

Onsite in Honduras, the local committees are old hands at organizing and managing large research events with 350+ participants in cancer screening programs called “jornadas.” Residents, including men, join studies enthusiastically and are proud to be part of an effort to make health care better internationally.

Other projects focus on education and the intersection with health. A major project tested a new way to teach farmers to spray pesticides more safely. In 2024, our primary research project is evaluation of Taking Care of You (TCY), a teen health education program with 78 consented participants. Findings of the TCY evaluation will inform development of the 2.0 version of the curriculum that may become standard in 17 associated high schools.

Published Work

Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries

Reducing dermal exposure to agrochemical carcinogens using a fluorescent dye-based intervention among subsistence farmers in rural Honduras

Opportunistic Breast Cancer Education and Screening in Rural Honduras

Screening for Human Papillomavirus in a Low- and Middle-Income Country

HPV, vaccines, and cervical cancer in a low- and middle-income country

Rural distribution of human papilloma virus in low- and middle-income countries